Your browser doesn't support javascript.
loading
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study.
Poos, Jackie M; Russell, Lucy L; Peakman, Georgia; Bocchetta, Martina; Greaves, Caroline V; Jiskoot, Lize C; van der Ende, Emma L; Seelaar, Harro; Papma, Janne M; van den Berg, Esther; Pijnenburg, Yolande A L; Borroni, Barbara; Sanchez-Valle, Raquel; Moreno, Fermin; Laforce, Robert; Graff, Caroline; Synofzik, Matthias; Galimberti, Daniela; Rowe, James B; Masellis, Mario; Tartaglia, Carmela; Finger, Elizabeth; Vandenberghe, Rik; de Medonça, Alexandre; Tagliavini, Fabrizio; Butler, Chris R; Santana, Isabel; Ber, Isabelle Le; Gerhard, Alex; Ducharme, Simon; Levin, Johannes; Danek, Adrian; Otto, Markus; Sorbi, Sandro; Pasquier, Florence; van Swieten, John C; Rohrer, Jonathan D.
Afiliação
  • Poos JM; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Russell LL; Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
  • Peakman G; Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
  • Bocchetta M; Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
  • Greaves CV; Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
  • Jiskoot LC; Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
  • van der Ende EL; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Seelaar H; Dementia Research Centre Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology London UK.
  • Papma JM; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • van den Berg E; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Pijnenburg YAL; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Borroni B; Department of Neurology Erasmus Medical Center Rotterdam the Netherlands.
  • Sanchez-Valle R; Department of Neurology Alzheimer Center Location VU University Medical Center Amsterdam Amsterdam the Netherlands.
  • Moreno F; Centre for Neurodegenerative Disorders Department of Clinical and Experimental Sciences University of Brescia Brescia Italy.
  • Laforce R; Alzheimer's Disease and Other Cognitive Disorders Unit Neurology Service Hospital Clínic Institut d'Investigacións Biomèdiques August Pi I Sunyer University of Barcelona Barcelona Spain.
  • Graff C; Cognitive Disorders Unit Department of Neurology Donostia University Hospital San Sebastian Gipuzkoa Spain.
  • Synofzik M; Neuroscience Area Biodonostia Health Research Institute San Sebastian Gipuzkoa Spain.
  • Galimberti D; Clinique Interdisciplinaire de Mémoire Département des Sciences Neurologiques CHU de Québec Faculté de Médecine Université Laval Quebec Canada.
  • Rowe JB; Center for Alzheimer Research, Division of Neurogeriatrics Department of Neurobiology, Care Sciences and Society Bioclinicum Karolinska Institutet Solna Sweden.
  • Masellis M; Unit for Hereditary Dementias Theme Aging Karolinska University Hospital Solna Sweden.
  • Tartaglia C; Department of Neurodegenerative Diseases Hertie-Institute for Clinical Brain Research and Center of Neurology University of Tübingen Tübingen Germany.
  • Finger E; Center for Neurodegenerative Diseases (DZNE) Tübingen Germany.
  • Vandenberghe R; Department of Biomedical, Surgical and Dental Sciences University of Milan Milan Italy.
  • de Medonça A; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy.
  • Tagliavini F; Department of Clinical Neurosciences Cambridge University Hospitals NHS Trust Medical Research Council Cognition and Brain Sciences Unit University of Cambridge Cambridge UK.
  • Butler CR; Sunnybrook Health Sciences Centre Sunnybrook Research Institute University of Toronto Toronto Canada.
  • Santana I; Tanz Centre for Research in Neurodegenerative Diseases University of Toronto Toronto Canada.
  • Ber IL; Department of Clinical Neurological Sciences University of Western Ontario London Canada.
  • Gerhard A; Laboratory for Cognitive Neurology Department of Neurosciences KU Leuven Leuven Belgium.
  • Ducharme S; Neurology Service University Hospitals Leuven Leuven Belgium.
  • Levin J; Leuven Brain Institute KU Leuven Leuven Belgium.
  • Danek A; Laboratory of Neurosciences Institute of Molecular Medicine Faculty of Medicine University of Lisbon Lisbon Portugal.
  • Otto M; Fondazione IRCCS Istituto Neurologico Carlo Besta Milan Italy.
  • Sorbi S; Nuffield Department of Clinical Neurosciences Medical Sciences Division University of Oxford Oxford UK.
  • Pasquier F; Department of Brain Sciences Imperial College London London UK.
  • van Swieten JC; University Hospital of Coimbra (HUC) Neurology Service Faculty of Medicine University of Coimbra Coimbra Portugal.
  • Rohrer JD; Center for Neuroscience and Cell Biology Faculty of Medicine University of Coimbra Coimbra Portugal.
Alzheimers Dement (Amst) ; 13(1): e12185, 2021.
Article em En | MEDLINE | ID: mdl-34027016
ABSTRACT

INTRODUCTION:

We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the Free and Cued Selective Reminding Test (FCSRT).

METHODS:

The FCSRT was administered in 417 presymptomatic and symptomatic mutation carriers (181 chromosome 9 open reading frame 72 [C9orf72], 163 progranulin [GRN], and 73 microtubule-associated protein tau [MAPT]) and 290 controls. Group differences and correlations with other neuropsychological tests were examined. We performed voxel-based morphometry to investigate the underlying neural substrates of the FCSRT.

RESULTS:

All symptomatic mutation carrier groups and presymptomatic MAPT mutation carriers performed significantly worse on all FCSRT scores compared to controls. In the presymptomatic C9orf72 group, deficits were found on all scores except for the delayed total recall task, while no deficits were found in presymptomatic GRN mutation carriers. Performance on the FCSRT correlated with executive function, particularly in C9orf72 mutation carriers, but also with memory and naming tasks in the MAPT group. FCSRT performance also correlated with gray matter volumes of frontal, temporal, and subcortical regions in C9orf72 and GRN, but mainly temporal areas in MAPT mutation carriers.

DISCUSSION:

The FCSRT detects presymptomatic deficits in C9orf72- and MAPT-associated FTD and provides important insight into the underlying cause of memory impairment in different forms of FTD.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Ano de publicação: 2021 Tipo de documento: Article